Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

PM Briefings from 9 Feb 2016 Innovation Network event

1,198 views

Published on

CDE enduring competition and creating effective CDE proposals

Published in: Technology
  • Be the first to comment

  • Be the first to like this

PM Briefings from 9 Feb 2016 Innovation Network event

  1. 1. CDE enduring competition
  2. 2. Enduring competition
  3. 3. Enduring competition
  4. 4. Enduring challenges
  5. 5. Protection
  6. 6. Situational awareness
  7. 7. Situational awareness
  8. 8. Power and energy
  9. 9. Power and energy
  10. 10. Communication
  11. 11. Data
  12. 12. Data
  13. 13. Data
  14. 14. Lethality
  15. 15. Lethality
  16. 16. Mobility
  17. 17. Mobility
  18. 18. Human performance
  19. 19. Human performance
  20. 20. Human performance
  21. 21. Human performance
  22. 22. Lower cost of ownership
  23. 23. Enduring challenge links
  24. 24. How can you get involved?
  25. 25. Centre for Defence Enterprise Advanced Design and Manufacturing Wing Commander Jim Pennycook Centre for Defence Enterprise 030 67704236 030 67704237 cde@dstl.gov.uk www.gov.uk/dstl/cde
  26. 26. Medical sciences part of human performance CDE enduring competition UK OFFICIAL© Crown copyright 2014 Dstl 10 February 2016
  27. 27. Human performance: enduring competition UK OFFICIAL© Crown copyright 2013 Dstl 10 February 2016 Context • the human component is central to delivering military capability • provision of sufficient, capable and appropriately trained personnel is critical to operational success • need to sustain capability by protection, treatment and rehabilitation • high quality support, care and treatment at all points along the continuum of care
  28. 28. Human performance: enduring competition 10 February 2016 © Dstl 2014 Themes Systems interface Survivability Sustainment Training and education Medical sciences Physical and mental health UK OFFICIAL
  29. 29. Human performance: enduring competition Defence Human and Medical Sciences will be intrinsic to Future Force Capability. Whole Force supported through Whole Service Life Care will be the foundation of next generation defence personnel. The Future Force will achieve a symbiotic relationship with technology, engendering enhanced information management and exploitation, shaping and influencing the defence and security landscape. UK OFFICIAL© Crown copyright 2014 Dstl 10 February 2016 People matter
  30. 30. Human performance: enduring competition UK OFFICIAL Humans in systems • human optimisation through augmentation • enhanced integrated systems • adaptive technologies • operation of complex socio- technical systems © Crown copyright 2013 Dstl 10 February 2016
  31. 31. Human performance: enduring competition UK OFFICIAL Defence personnel • supply • capability • motivation • workforce management • organisational design © Crown copyright 2013 Dstl 10 February 2016
  32. 32. Human performance: enduring competition UK OFFICIAL Training and education • evaluation of alternative training methods and approaches • technology assessments applied to the military environment • development of training standards and guidance • demonstration of training tools for specific environments © Crown copyright 2013 Dstl 10 February 2016
  33. 33. Medical Sciences research programme Providing research which contributes to an improvement in physical, psychological and social health, in order to maintain operational effectiveness and minimise mortality, morbidity and residual disability © Crown copyright 2013 Dstl 10 February 2016
  34. 34. CSA Medical Science programme • medical science: £3 million • medical operational analysis: £450,000 • support for National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre(NIHR SRMRC): £1 million © Crown copyright 2013 Dstl 10 February 2016
  35. 35. Medical Sciences research programme to address Defence Medical Services’ research outcomes © Crown copyright 2013 Dstl 10 February 2016 Increased survival Reduced recovery times Reduced medical discharge Improved medical training and equipment Improved force effectiveness Improved functional recovery
  36. 36. Research areas with associated priorities Combat casualty care Whole life service care Medical Systems & logistics Simulation for training & education Health surveillance & informatics Medical OA Rehabilitation Regenerative medicine Environmental & occupational injuries Mental health Resuscitation Haemorrhage control Pain management Austere environments Extended evacuation times Noise Cold Supply of medical capability Big data Freedom from fridges & freezers
  37. 37. Human performance: enduring competition 10 February 2016 Medical Sciences • human performance and protection • systems for medics and first responders • simulated environments in defence medical training • rehabilitation and regenerative medicine within defence • fit to deploy • operational health and protection • information and analysis UK OFFICIAL
  38. 38. Exploitation UK OFFICIAL© Crown copyright 2013 Dstl 10 February 2016 Follow-on activities • stakeholder demonstration Research integration • medical sciences programme Procurement • refine, trial or purchase Policy • refinement and implementation • development of doctrine
  39. 39. Chemical, Biological and Radiological Science and Technology Programme
  40. 40. UNCLASSIFIED Overview Context Strategic view Programme vision and breadth of activities What do we need to address? © Crown 10 February 2016
  41. 41. UNCLASSIFIED 10 February 2016
  42. 42. UNCLASSIFIED 10 February 2016
  43. 43. UNCLASSIFIED National Security Strategy and Strategic Defence and Security Review 2015 10 February 2016
  44. 44. UNCLASSIFIED The next 5 years 10 February 2016
  45. 45. UNCLASSIFIED The longer term The following aspects of the Tier 1 and 2 risks may become even more likely and/or have a greater impact over the longer term: • antimicrobial resistance • cyber related threats • chemical and biological attacks against the UK or its forces • pressure on allies or undermining of our military and economic alliances and institutions • emerging infectious diseases • serious and organised crime, eg human trafficking • proliferation: acquisition of nuclear, chemical and biological weapons (CBW), and advanced conventional weapons by state and non-state actors 10 February 2016
  46. 46. UNCLASSIFIED 10 February 2016 The CBW spectrum illustrates the range of materials that could be used as CBW agents Toxic industrial chemicals (TICS) Major CW agents Emerging CW agents Mid spectrum agents BW agents HCN Phosgene chlorine ammonia vesicants nerve agents psycho- chemicals developments from pharmaceutical & pesticide research (Moscow theatre) toxins bioregulators bacteria rickettsia viruses increasing potency (up to~1012) synthetic chemicals self-replicating agents of biological origin
  47. 47. UNCLASSIFIED Programme vision Through the contribution of science and technology: • Chemical, Biological and Radiological (CBR) weapons/materials will have no strategic or tactical effect • perpetrators will be identified • restraint is rewarded and acceptable norms are reinforced 10 February 201610 February 2016
  48. 48. UNCLASSIFIED Breadth of activities Proof of concept Support to operations Innovation Supporting policy Technology transfer Test and evaluation 10 February 2016
  49. 49. UNCLASSIFIED 10 February 2016 How do we know if there's been a release of a biological agent, distinguish it from background and inform a timely response?
  50. 50. UNCLASSIFIED 10 February 2016 How can we identify a covert facility producing a chemical or biological agent?
  51. 51. UNCLASSIFIED © Crown 10 February 2016 How do we know if an individual has been exposed to a biological agent in a timely manner (before symptoms)? Can we modulate the immune system to improve the chances of survival: • after exposure to a biological agent • before symptoms • before identification of the agent?
  52. 52. UNCLASSIFIED 10 February 2016 How do we maintain high levels of protection for our armed forces but reduce the burden? Especially important when they need to do something
  53. 53. UNCLASSIFIED 10 February 2016 How do we know if something is contaminated and what’s the best way of dealing with that?
  54. 54. UNCLASSIFIED 10 February 2016 If a large stockpile of chemical weapons were needed to be dealt with, what’s the best, quickest and most expedient way of dealing with it?
  55. 55. UNCLASSIFIED 10 February 2016 How can we influence the international community by reinforcing what’s acceptable and what isn't, particularly where conventions don’t apply?
  56. 56. UNCLASSIFIED 10 February 2016 Back to the vision – can we make the use of CBW weapons obsolete because we don’t want to see this
  57. 57. UNCLASSIFIED Exploitation • CBR technical advice and reach-back – UK government, defence, Organisation for the Prohibition of Chemical Weapons (OPCW) • MOD capability – UK Armed Forces • Cross-government science and technology capabilities • International partners and allies 10 February 2016
  58. 58. UNCLASSIFIED 10 February 2016 QUESTIONS?
  59. 59. © Crown copyright 2013 Dstl 10 February 2016
  60. 60. Guidance on submitting CDE research proposals
  61. 61. Aims
  62. 62. Competition Summary Innovation details Finance and delivery schedule Review and submit Submission to competition: steps 1 > 5 CDE submission service
  63. 63. Competition Summary Innovation details Finance and delivery schedule Review and submit Step 1
  64. 64. Competition Summary Innovation details Finance and delivery schedule Review and submit Step 2
  65. 65. Competition Summary Innovation details Finance and delivery schedule Review and submit Step 3
  66. 66. The idea The benefit The impact The approach The deliverables Five factors
  67. 67. The idea
  68. 68. The benefit
  69. 69. The impact
  70. 70. The approach
  71. 71. The deliverables
  72. 72. The deliverables
  73. 73. Step 3
  74. 74. Step 3 A. The Idea B. Defence and security relevance C. Your work plan and research approach D. Exploitation beyond the proof-of concept stage
  75. 75. Step 3
  76. 76. Step 3
  77. 77. Step 3
  78. 78. Step 3
  79. 79. Competition Summary Innovation details Finance and delivery schedule Review and submit Step 4
  80. 80. Competition Summary Innovation details Finance and delivery schedule Review and submit Step 5
  81. 81. Bidder dashboard 4/5
  82. 82. IN ASSESSMENT SUBMITTED FUND NO FUND Proposal status
  83. 83. Watermarking
  84. 84. CDE assessment
  85. 85. CDE assessment A. Operational relevance B. Likelihood of exploitation C. Builds critical S&T capability to meet UK needs D. Scientific quality / innovation E. Pushing the limits (S&T risk) A. Impact on defence and security B. Likelihood of exploitation C. Advancing important science and technology D. Innovation and scientific quality E. Technical challenge
  86. 86. Impact on defence and security
  87. 87. Likelihood of exploitation
  88. 88. Advancing important S&T
  89. 89. Innovation and scientific quality
  90. 90. Technical challenge
  91. 91. And finally…..
  92. 92. Proposal health check
  93. 93. Effective proposals
  94. 94. Questions? Centre for Defence Enterprise cde@dstl.gov.uk www.gov.uk/dstl/cde
  95. 95. Questions

×